Abstract TGF-b has several anti-inflammatory proper-the immune system and inflammatory processes, generally functioning as an endogenous immunosuppressive, ties which may be relevant to prevention of or recovery from acute glomerular inflammation. Using genetically anti-inflammatory factor. TGF-b represses B cell proliferation and immunoglobulin secretion, mitogenesis modified mesangial cells and a technique for in vivo macrophage transfer, this article provides evidence for and cytokine production of thymocytes/T lymphocytes and cytotoxic action of natural killer cells. TGF-b TGF-b-mediated 'self-defence' of the glomerulus against macrophages. Rat mesangial cells stably trans-inhibits adhesion of neutrophils and T cells to the endothelium and deactivates macrophages at picomofected with TGF-b1 showed a blunted response to the macrophage-derived, proinflammatory cytokine IL-1b. lar concentrations. Systemic administration of TGF-b attenuates the activity of experimental autoimmune In contrast, mesangial cells expressing the dominantinterfering TGF-b receptor showed an enhanced diseases including collagen arthritis, allergic encephalomyelitis, insulitis, Sjö gren's syndrome, and systemic response to IL-1. Similarly, externally added TGF-b1 inhibited the cytokine response of normal glomeruli, lupus erythematosus. Furthermore, targeted disruption of TGF-b1 via homologous recombination induces and isolated nephritic glomeruli producing active TGFb1 showed a depressed response to IL-1b, compared multi-organ inflammation and early death in mice, indicating the crucial role of TGF-b in the maintenance to normal glomeruli. Consistent with these in vitro results, in vivo transfer of activated macrophages of integrity of normal organ function. The detail of the anti-inflammatory properties of TGF-b has been revealed that the TGF-b-producing glomeruli are insensitive to the effector action of macrophages. These summarized in a recent review [1]. results indicate that TGF-b1 functions as an endogenous 'defender' that counteracts local action of activated macrophages in the glomerulus.
Introduction
However, this molecule has several properties which may be 'beneficial' during glomerular inflammation. For example, in vitro, externally added TGF-b inhibits It is almost 20 years since TGF-b emerged from the mitogenesis of glomerular epithelial, endothelial, and backwater of modern biology. It is now well-recognized mesangial cells [3] [4] [5] . Similarly, the mitogenic response that TGF-b is a pleiotropic cytokine involved in a of isolated normal glomeruli is inhibited by TGF-b1 wide range of pathophysiological processes. In general, [6 ] . Mesangial cells and/or glomeruli treated with TGF-b is considered as a pro-fibrotic cytokine involved TGF-b1 show blunted responses to IL-1b and TNF-a in organ fibrogenesis. This is based on the notion that [6] [7] [8] [9] . Using an ex vivo gene transfer approach, it has TGF-b induces deposition of extracellular matrix via been shown that in vivo mitogenesis of glomerular cells stimulating production of matrix proteins, decreasing in acute glomerulonephritis (GN ) could be suppressed synthesis of matrix-degrading proteinases and upregulby introduction of a cDNA coding for the active form ating synthesis of proteinase inhibitors. On the other of TGF-b1 [6]. hand, TGF-b is also known as a potent regulator of TGF-b is a prominent deactivator of macrophages which play a crucial role in the generation of glomerCorrespondence and offprint requests to: M. Kitamura, Glomerular ular injury. For example, TGF-b strongly inhibits Bioengineering Unit, Department of Medicine, University College macrophage production of reactive oxygen/nitrogen London Medical School, The Rayne Institute, 5 University Street, London WC1E 6JJ, UK.
species [10] , the important pathogenic mediators in Population of BAGMACNR macrophages in glomeruli after renal artery injection. BAGMACNR cells were injected into the left kidneys of rats via the renal artery. Glomeruli isolated from left kidneys were subjected to X-gal assay. Light microscopy (×100). (C ) Blunted induction of stromelysin in TGF-b producing, nephritic glomeruli after transfer of activated macrophages. BAGMACNR macrophages were stimulated with lipopolysaccharide and transferred into normal rat glomeruli (normal ) or inflamed glomeruli subjected to anti-Thy1 GN (nephritic). One-third of isolated glomeruli were immediately frozen at −80°C (day 0: d0). The remaining glomeruli were incubated for 24 h in medium containing 1% FCS in the presence (+) or absence (−) of G418 and then stored at −80°C (day 1: d1). Expression of stromelysin was examined by Northern blot analysis. Expression of b-actin is shown as a loading control. RK, Unmodified right kidney; LK, macrophage-transferred left kidney.
GN. It has been reported that mesangial cell-derived showed that externally added TGF-b1 blunted a mesangial cell response to the macrophage-derived cyto-TGF-b1 impairs the adhesiveness of macrophages to substrata [11] and inhibits macrophage production of kine, IL-1b [6 ] . To examine how the autocrine loop of TGF-b modulates responses of mesangial cells to IL-1b, IL-6, TNF-a, and monocyte chemoattractant protein-1 in response to lipopolysaccharide [12, 13] .
macrophage-derived cytokines, rat mesangial cells were stably transfected with a cDNA encoding the active form of TGF-b1 or a cDNA coding for the transdomin- [16 ] . The established BAGMACNR References cells exhibited a high level of transgene expression [16 ] and b-galactosidase activity ( Figure 1A) . BAGMACNR 
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